SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-14-007796
Filing Date
2014-05-02
Accepted
2014-05-02 09:11:27
Documents
13
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ipxl20140331_10q.htm 10-Q 1281972
2 EXHIBIT 10.2 ex10-2.htm EX-10 13809
3 EXHIBIT 31.1 ex31-1.htm EX-31 19301
4 EXHIBIT 31.2 ex31-2.htm EX-31 19599
5 EXHIBIT 32.1 ex32-1.htm EX-32 7572
6 EXHIBIT 32.2 ex32-2.htm EX-32 7840
13 heading1.jpg GRAPHIC 8529
  Complete submission text file 0001437749-14-007796.txt   8884932

Data Files

Seq Description Document Type Size
7 EXHIBIT 101.INS ipxl-20140331.xml EX-101.INS 1441838
8 EXHIBIT 101.SCH ipxl-20140331.xsd EX-101.SCH 77344
9 EXHIBIT 101.CAL ipxl-20140331_cal.xml EX-101.CAL 47333
10 EXHIBIT 101.DEF ipxl-20140331_def.xml EX-101.DEF 295922
11 EXHIBIT 101.LAB ipxl-20140331_lab.xml EX-101.LAB 485743
12 EXHIBIT 101.PRE ipxl-20140331_pre.xml EX-101.PRE 299507
Mailing Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544 510-240-6000
IMPAX LABORATORIES INC (Filer) CIK: 0001003642 (see all company filings)

IRS No.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34263 | Film No.: 14807116
SIC: 2834 Pharmaceutical Preparations